Pfiz­er set­tles EpiPen price hike law­suits for $345M

Pfiz­er has agreed to pay $345 mil­lion as part of a set­tle­ment re­lat­ed to a 5-year-old law­suit over the com­pa­ny’s price hikes on the life­sav­ing EpiPen.

Plain­tiffs across the coun­try raised con­cerns over the price of the au­toin­jec­tor 2-pack, which they said spiked from about $100 in 2007 to $608 in 2016 — an in­crease of over 600%.

“Were the price in­creas­es at­trib­ut­able to mar­ket con­di­tions, in­creas­es in man­u­fac­tur­ing costs, or short­ages in the sup­ply of ep­i­neph­rine? Ab­solute­ly not. They were dri­ven sole­ly by un­ac­count­able ex­ec­u­tives and com­pa­nies who sought to prof­it off of hu­man mis­ery and fear,” the con­sol­i­dat­ed class ac­tion com­plaint from 2017 al­leged.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.